Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study
- PMID: 17244809
- DOI: 10.1099/jmm.0.46817-0
Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study
Abstract
Bloodstream infections due to Candida species are important complications in severely ill hospitalized patients. This study presents data on species distribution and antifungal susceptibility profiles of Candida bloodstream isolates obtained from Kuwait during a 10-year period. All the bloodstream isolates were identified to species level by the germ tube test and carbohydrate assimilation profile using the VITEK 2 yeast identification system. Using E-test strips for amphotericin B, fluconazole, 5-flucytosine and voriconazole, MICs were determined on RPMI agar supplemented with 2% glucose. The MIC breakpoints for resistance were based on Clinical and Laboratory Standards Institute criteria or those published by reference laboratories, and were as follows: amphotericin B, >1 microg ml-1; fluconazole, >or=64 microg ml-1; 5-flucytosine, >or=32 microg ml-1; and voriconazole, 4 microg ml-1. In all, 607 bloodstream yeast isolates were obtained over the past 10 years in Kuwait. Candida albicans was the predominant species (39.5%), followed by Candida parapsilosis (30.6%), Candida tropicalis (12.4%), Candida glabrata (5.6%) and Candida krusei (1.6%). All C. albicans, C. tropicalis and C. glabrata isolates were susceptible to amphotericin B. Of 186 isolates of C. parapsilosis tested, only four (2%) exhibited an MIC for amphotericin B of >1 microg ml-1. Resistance to fluconazole was observed in nine (3.8%) C. albicans isolates, two (5.8%) C. glabrata isolates and four (40%) C. krusei isolates. Resistance to 5-flucytosine was observed in two (0.8%) C. albicans isolates, seven (9.3%) C. tropicalis isolates, three (1.6%) C. parapsilosis isolates and all ten (100%) C. krusei isolates. All the isolates of C. albicans, C. tropicalis, C. parapsilosis, C. glabrata and C. krusei were susceptible to voriconazole, including those resistant to fluconazole. Although amphotericin B and fluconazole are widely used in clinical practice in Kuwait, resistance to these drugs remained low.
Similar articles
-
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].Mikrobiyol Bul. 2016 Jan;50(1):122-32. doi: 10.5578/mb.10682. Mikrobiyol Bul. 2016. PMID: 27058336 Turkish.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.J Antimicrob Chemother. 2015 Mar;70(3):802-10. doi: 10.1093/jac/dku460. Epub 2014 Dec 3. J Antimicrob Chemother. 2015. PMID: 25473027
-
Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.Med Mycol. 2003 Jun;41(3):235-9. doi: 10.1080/1369378031000137198. Med Mycol. 2003. PMID: 12964715
-
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.Clin Microbiol Infect. 2004 Mar;10 Suppl 1:11-23. doi: 10.1111/j.1470-9465.2004.t01-1-00844.x. Clin Microbiol Infect. 2004. PMID: 14748799 Review.
Cited by
-
The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms.Saudi Pharm J. 2015 Jan;23(1):55-66. doi: 10.1016/j.jsps.2013.12.007. Epub 2013 Dec 22. Saudi Pharm J. 2015. PMID: 25685044 Free PMC article.
-
Comparison Between Biofilm Production, Phospholipase and Haemolytic Activity of Different Species of Candida Isolated from Dental Caries Lesions in Children.J Clin Diagn Res. 2016 Apr;10(4):DC21-3. doi: 10.7860/JCDR/2016/17019.7643. Epub 2016 Apr 1. J Clin Diagn Res. 2016. PMID: 27190803 Free PMC article.
-
Prevalent drug resistance among oral yeasts from asymptomatic patients in Hainan, China.Mycopathologia. 2014 Jun;177(5-6):299-307. doi: 10.1007/s11046-014-9747-3. Epub 2014 May 10. Mycopathologia. 2014. PMID: 24816793
-
The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.Pan Afr Med J. 2020 May 19;36:23. doi: 10.11604/pamj.2020.36.23.18202. eCollection 2020. Pan Afr Med J. 2020. PMID: 32774600 Free PMC article.
-
Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait.PLoS One. 2019 May 1;14(5):e0216250. doi: 10.1371/journal.pone.0216250. eCollection 2019. PLoS One. 2019. PMID: 31042770 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous